Drug Discovery for Immune System Rejuvenation
The first drug discovery platform for immune system rejuvenation.
img-1
Our Mission Immune system
Reboot
Reboot
Our platform enables the expansion and rejuvenation of bone marrow stem cells (HSCs) and other immune cell types. We envision a future population that always has a bone marrow donor, is more resistant to pandemics, and is more resilient to cancer. Ultimately, we aim to reduce the time we spend in hospitals and maximize healthy and productive years of life.
Our Technology Dual Rejuvenation
Platform
Platform
StemSupply Platform 
We can expand hematopoietic stem cell (HSC) numbers by >1,000x, which is unprecedented. This allows for better bone marrow transplants as well as high throughput drug screening on human HSCs, for the first time ever.
AgeScreen: Geroscience Drug Discovery Engine
We have developed a series of assays to identify new molecules which regulate cellular aging and immune cell aging in particular.
Our Team 100+ Years Combined Drug
Discovery Expertise
Discovery Expertise
img-2
about us Deep Expertise In LongBio
And Immunology
And Immunology
ImmuneAGE Bio is the first drug discovery platform company focused on immune system rejuvenation. ImmuneAGE rejuvenates hematopoietic stem cells (HSCs) from the bone marrow based on a geroscience screening platform enabled by a new ‘StemSupply’ method achieving >1000x expansion of HSCs.